Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Cureus|May 7, 2019
First-ever Abscopal Effect after Palliative Radiotherapy and Immuno-gene Therapy for Malignant Pleural MesotheliomaAndrew R Barsky, Keith A Cengel, Sharyn I Katz, et al.
Journal of Thoracic Imaging|August 22, 2024
Radiomics Analysis for the Identification of Invasive Pulmonary Subsolid Nodules From Longitudinal Presurgical CT ScansApurva Singh, Leonid Roshkovan, Hannah Horng, et al.
Scientific Reports|December 13, 2022
Resampling and harmonization for mitigation of heterogeneity in image parameters of baseline scansApurva Singh, Hannah Horng, Rhea Chitalia, et al.
Photochemistry and Photobiology|December 1, 2018
Modeling Epidermal Growth Factor Inhibitor-mediated Enhancement of Photodynamic Therapy Efficacy Using 3D Mesothelioma Cell CultureGwendolyn Cramer, Michael Shin, Sarah Hagan, et al.
Current Problems in Diagnostic Radiology|March 26, 2018
Thoracic Imaging of Non-Small Cell Lung Cancer Treated With Anti-programmed Death Receptor-1 TherapyMark Hammer, Stephen Bagley, Charu Aggarwal, et al.
International Journal of Oncology|May 4, 2011
FLT-PET may not be a reliable indicator of therapeutic response in p53-null malignancySharyn I Katz, Lanlan Zhou, Thomas A Ferrara, et al.
Lung Cancer (Amsterdam, Netherlands)|March 20, 2019
Imaging in pleural mesothelioma: A review of the 14th International Conference of the International Mesothelioma Interest GroupSamuel G Armato, Roslyn J Francis, Sharyn I Katz, et al.
Academic Radiology|February 10, 2019
Patient-Centered and Specialty-Specific Case Work-Up: An Effective Method for Teaching Appropriateness of Imaging to Medical StudentsMike Sheng, Preya Shah, John M Choi, et al.
Cancer Biology & Therapy|December 30, 2009
Sorafenib inhibits ERK1/2 and MCL-1(L) phosphorylation levels resulting in caspase-independent cell death in malignant pleural mesotheliomaSharyn I Katz, Lanlan Zhou, Grace Chao, et al.
Scientific Reports|October 3, 2025
Development of a prognostic multiomic biomarker of progression-free survival in advanced non-small cell lung cancer patients treated with first line immunotherapyApurva Singh, Hannah Horng, Leonid Roshkovan, et al.
Pageof 6